Score in phase I CML trial has Enliven looking ahead to phase III

AI Briefing

• – • Enliven's phase I CML trial shows promising results with a positive score.
• – • The company is optimistic about advancing to phase III trials.
• – • Phase III trials are a crucial step in securing FDA approval for new treatments.